Back to search
Scleroderma (Limited and Diffuse)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Scleroderma (Limited and Diffuse) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Scleroderma (Limited and Diffuse) trials you may qualify forThe main purpose of the study is to investigate the efficacy on cutaneous thickness and the safety of Nemolizumab in adult patients with systemic sclerosis afte…
This study aims to investigate the effectiveness of BETY, an exercise approach based on the biopsychosocial model, in children and adults diagnosed with sclerod…
Physical functionality and performance are important for individuals diagnosed with scleroderma. There is a need to address children and adults diagnosed with s…
It is recommended to focus on the physical functionality, chewing, and swallowing performance of individuals diagnosed with scleroderma. There is a need to addr…
The Patient Self-Assessment of Skin Thickness in Upper Limb (PASTUL) questionnaire was developed to enable patients to assess skin thickness in systemic scleros…
The purpose of this study is to evaluate the efficacy and safety of treatment with subcutaneous anifrolumab versus placebo in adult participants with systemic s…
The purpose of this phase 2 multicenter, randomized, double-blind, placebo-controlled, study is to assess the safety and efficacy of ifetroban in patients with…